Literature DB >> 16633772

Syndrome of inappropriate secretion of antidiuretic hormone associated with paroxetine.

Takeshi Kubota1, Akimasa Miyata.   

Abstract

A 71-year old man with failed back syndrome was admitted to hospital with oliguria that had occurred 4 days after his dose of paroxetine had been increased to 40 mg x day(-1). Laboratory data on admission revealed hyponatremia (124 mmol x l(-1)), low serum osmolarity (267 mOsm x l(-1)) with a normal level of serum antidiuretic hormone (1.7 pg x ml(-1)), and concentrated urine (430 mOsm x l(-1)). He was diagnosed as having syndrome of inappropriate secretion of antidiuretic hormone, associated with paroxetine; this drug was discontinued immediately after admission. The hyponatremia was treated with saline infusion, water restriction, and furosemide; serum sodium level returned to normal on hospital day 5. Paroxetine is being increasingly used for depression and chronic pain management because of its favorable side-effect profile; however, we should be alert to hyponatremia in patients on paroxetine by carrying out periodic monitoring of serum electrolytes, especially in elderly patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16633772     DOI: 10.1007/s00540-005-0381-6

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  11 in total

1.  A case of SSRI-induced hyponatremia.

Authors:  Kip A Corrington; Coley C Gatlin; Karl B Fields
Journal:  J Am Board Fam Pract       Date:  2002 Jan-Feb

2.  An unusually rapid onset of hyponatraemia following paroxetine.

Authors:  S Paul; S K Sankaran
Journal:  Aust N Z J Med       Date:  1998-12

3.  The efficacy of selective serotonin reuptake inhibitors for the management of chronic pain.

Authors:  A C Jung; T Staiger; M Sullivan
Journal:  J Gen Intern Med       Date:  1997-06       Impact factor: 5.128

4.  Severe life-threatening hyponatremia during paroxetine therapy.

Authors:  M Odeh; H Seligmann; A Oliven
Journal:  J Clin Pharmacol       Date:  1999-12       Impact factor: 3.126

5.  Hyponatremia upon resumption of paroxetine therapy.

Authors:  Masayuki Wakita; Hideki Matsuoka; Rikuzo Hamada; Hideki Okatsu; Takahiro Nakajima; Mitsuhiro Osame
Journal:  Intern Med       Date:  2005-03       Impact factor: 1.271

6.  Incidence and risk factors for hyponatraemia following treatment with fluoxetine or paroxetine in elderly people.

Authors:  T J Wilkinson; E J Begg; A C Winter; R Sainsbury
Journal:  Br J Clin Pharmacol       Date:  1999-02       Impact factor: 4.335

Review 7.  Paroxetine: a review.

Authors:  M Bourin; P Chue; Y Guillon
Journal:  CNS Drug Rev       Date:  2001

Review 8.  Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone associated with the use of selective serotonin reuptake inhibitors: a review of spontaneous reports.

Authors:  B A Liu; N Mittmann; S R Knowles; N H Shear
Journal:  CMAJ       Date:  1996-09-01       Impact factor: 8.262

9.  Paroxetine-induced hyponatremia in the elderly due to the syndrome of inappropriate secretion of antidiuretic hormone (SIADH).

Authors:  Tanya J Fabian; Janet A Amico; Patricia D Kroboth; Benoit H Mulsant; Charles F Reynolds; Bruce G Pollock
Journal:  J Geriatr Psychiatry Neurol       Date:  2003-09       Impact factor: 2.680

10.  Hyponatremia following acute overdose with paroxetine.

Authors:  C R Johnsen; N Hoejlyng
Journal:  Int J Clin Pharmacol Ther       Date:  1998-06       Impact factor: 1.366

View more
  1 in total

1.  Hyponatremia associated with paroxetine induced by sodium-restricted diet and hypotonic saline.

Authors:  Tetsuro Koide; Toru Wakabayashi; Toru Matsuda; Shinichiro Horiike; Keiko Watanabe
Journal:  Pharm World Sci       Date:  2009-12-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.